Glutamic Acid

Glutamic Acid

SCHEMBL3884849

N[C@@H](CCC(=O)O)C(=O)O.[Fe]

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM8 O00222 2/20 0.95
GRM6 O15303 2/20 0.95
GRM7 Q14831 2/20 0.95
GRM4 Q14833 2/20 0.95
GSR P00390 2/20 0.95
GRIN2D O15399 1/20 0.95
GRIN3B O60391 1/20 0.95
CYP1A2 P05177 1/20 0.95
GRIK1 P39086 1/20 0.95
GRM5 P41594 1/20 0.95
GRIA1 P42261 1/20 0.95
GRIA2 P42262 1/20 0.95
GRIA3 P42263 1/20 0.95
SLC1A3 P43003 1/20 0.95
SLC1A2 P43004 1/20 0.95
SLC1A1 P43005 1/20 0.95
GRIA4 P48058 1/20 0.95
GRIN1 Q05586 1/20 0.95
GRIN2A Q12879 1/20 0.95
GRIK2 Q13002 1/20 0.95

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
D-Glutamate SCHEMBL21072467 1.00 GRM8 (0.95) GRM8GRM6GRM7GRM4GSR
D-Glutamate SCHEMBL28877023 0.97 GRM8 (0.90) GRM8GRM6GRM7GRM4GSR
Glutamic Acid SCHEMBL28166196 0.97 GRM8 (0.90) GRM8GRM6GRM7GRM4GSR
D-Glutamate SCHEMBL28166198 0.97 GRM8 (0.90) GRM8GRM6GRM7GRM4GSR
D-Glutamate SCHEMBL2163608 0.97 GRM8 (0.90) GRM8GRM6GRM7GRM4GSR
Glutamic Acid SCHEMBL28877021 0.97 GRM8 (0.90) GRM8GRM6GRM7GRM4GSR
D-Glutamate SCHEMBL1330484 0.97 GRM8 (1.00) GRM8GRM6GRM7GRM4GSR
D-Glutamate SCHEMBL1330824 0.97 GRM8 (1.00) GRM8GRM6GRM7GRM4GSR
Glutamic Acid SCHEMBL5704264 0.97 GRM8 (1.00) GRM8GRM6GRM7GRM4GSR
D-Glutamate SCHEMBL2201 0.97 GRM8 (1.00) GRM8GRM6GRM7GRM4GSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024162590-A1 COMPOSITION FOR PREVENTING OR TREATING PROSTATIC HYPERTROPHY, CONTAINING, AS ACTIVE INGREDIENTS, SALVIA MILTIORRHIZA BUNGE EXTRACT, METAL MINERAL DIAMINATE AND URIDINE 주식회사 건강중심주의 2024-08-08 WO claimed
US-20230354814-A1 ENHANCED HERBICIDAL COMPOSITIONS OF TRANSITION METAL CHELATES W NEUDORFF GMBH KG (DE) 2023-11-09 US claimed
CN-112251475-B Method for improving L-glutamine fermentation yield and sugar-acid conversion rate 乐康珍泰(天津)生物技术有限公司 2022-09-13 CN claimed
CN-112538664-B Anti-counterfeiting bamboo pulp fiber, preparation method and anti-counterfeiting method 南通纺织丝绸产业技术研究院 2022-02-11 CN claimed
CN-112538664-A Anti-counterfeiting bamboo pulp fiber, preparation method and anti-counterfeiting method 南通纺织丝绸产业技术研究院 2021-03-23 CN claimed
CN-112094873-A Method for improving fermentation yield of L-isoleucine 乐康珍泰(天津)生物技术有限公司 2020-12-18 CN claimed
EP-3125699-A1 GROUND MEAT REPLICAS Impossible Foods Inc. (US) 2017-02-08 EP claimed
CN-103896673-B A kind of growth encourage type stable and synergistic water soluble fertilizer SHENYANG INSTITUTE OF APPLIED ECOLOGY, CHINESE ACADEMY OF SCIENCES (CN) 2016-01-20 CN claimed
WO-2015153666-A1 GROUND MEAT REPLICAS IMPOSSIBLE FOODS INC. (US) 2015-10-08 WO claimed
CN-103896672-A Polyion synergia stabilized urea ammonium nitrogen fertilizer and preparation method thereof INST APPLIED ECOLOGY CAS 2014-07-02 CN claimed
CN-103896673-A Growth-promoting stable and synergistic water soluble fertilizer INST APPLIED ECOLOGY CAS 2014-07-02 CN claimed
US-7375243-B2 electrically neutral and free of interfering ions, by reacting a metal carbonate and an acidic amino acid in an aqueous solution MD BIOALPHA CO., LTD. (KR) 2008-05-20 US claimed
EP-1569943-A4 METHOD FOR PREPARATION OF AMINO ACID CHELATE MD BIOALPHA CO LTD (KR) 2007-11-28 EP claimed
US-20060128799-A1 Method for preparation of amino acid chelate YUNGJIN PHARM. CO., LTD. (KR) 2006-06-15 US claimed
JP-2006509787-A 2006-03-23 JP claimed
CN-1720249-A Preparation method of amino acid chelate MD BIOALPHA CO LTD (KR) 2006-01-11 CN claimed
EP-1569943-A1 METHOD FOR PREPARATION OF AMINO ACID CHELATE Md Bioalpha Co., Ltd. (KR) 2005-09-07 EP claimed
WO-2004050664-A1 METHOD FOR PREPARATION OF AMINO ACID CHELATE MD BIOALPHA CO., LTD. (KR) 2004-06-17 WO claimed
WO-2004028548-A2 INHIBITORS OF THE NITRIX OXIDE SYNTHASE III (NOS III) AS NEUROPROTECTIVE AGENTS CARBOMER, INC. (US) 2004-04-08 WO claimed
US-20040063612-A1 Neuroprotective agents CARBOMER, INC. 2004-04-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128799-A1 Method for preparation of amino acid chelate SLC7A1, AAAS, AADAT GRM8 562/4885GRM6 374/4885GRM7 503/4885
US-20040063612-A1 Neuroprotective agents GAP43, NLN, NOS3 GRM8 701/4885GRM6 281/4885GRM7 569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.